The DOI matches its Crossref record.
Irreversible Electroporation Therapy in the Liver: Longitudinal Efficacy Studies in a Rat Model of Hepatocellular Carcinoma
Open accessAbstract
Irreversible electroporation (IRE) is an innovative local-regional therapy that involves delivery of intense electrical pulses to tissue to induce nanoscale cell membrane defects for tissue ablation. The purpose of this study was to investigate the feasibility of using IRE as a liver-directed ablation technique for the treatment of hepatocellular carcinoma (HCC). In the N1-S1 rodent model, hepatomas were grown in 30 Sprague-Dawley rats that were divided into treatment and control groups. For treatment groups, IRE electrodes were inserted and eight 100-μs 2,500-V pulses were applied to ablate the targeted tumor tissues. For both groups, magnetic resonance imaging scans were performed at baseline and 15-day follow-up intervals to determine tumor sizes (one-dimensional maximum diameter, Dmax; estimated two-dimensional cross-sectional area, Cmax) as a tactic to assess longitudinal outcomes. Additional groups of treated animals were sacrificed at 1-, 3-, and 7-day intervals posttherapy for pathology assessment of treatment response. Magnetic resonance images showed significant tumor size reductions within 15 days posttherapy (32 ± 31% Dmax and 52 ± 39% Cmax decreases compared with 110 ± 35% Dmax and 286 ± 125% Cmax increases for untreated tumors). Pathology correlation studies documented progression from poorly differentiated viable HCC tissues before treatment to extensive tumor necrosis and full regression in 9 of 10 treated rats 7 to 15 days after treatment. Our findings suggest that IRE can be an effective strategy for targeted ablation of liver tumors, prompting its further evaluation for HCC therapy. Cancer Res; 70(4); 1555–63
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
European Association for the Study of the Liver, & European Organisation for Research and Treatment of Cancer (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.12.001 · Cited by 5,218
“Irreversible electroporation is currently in clinical evaluation, after pre-clinical positive approach [282].”
BackgroundElectroporation-Based Technologies for Medicine: Principles, Applications, and Challenges
Yarmush, M. L., Golberg, A., Serša, G., Kotnik, T., & Miklavčič, D. (2014) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071813-104622 · Cited by 889
Cell death due to electroporation – A review
Batista Napotnik, T., Polajžer, T., & Miklavčič, D. (2021) · Bioelectrochemistry · doi:10.1016/j.bioelechem.2021.107871 · Cited by 542
Scheffer, H. J., Nielsen, K., de Jong, M. C., van Tilborg, A. A. J. M., Vieveen, J. M., Bouwman, A. (. A. )., Meijer, S., van Kuijk, C., van den Tol, P. (. P. )., & Meijerink, M. R. (2014) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2014.01.028 · Cited by 421
Cannon, R., Ellis, S., Hayes, D., Narayanan, G., & Martin, R. C. G. (2013) · Journal of Surgical Oncology · doi:10.1002/jso.23280 · Cited by 338
Metadata
- Authors
- Guo, Y., Zhang, Y., Klein, R., Nijm, G. M., Sahakian, A. V., Omary, R. A., Yang, G.-Y., & Larson, A. C.
- Venue
- Cancer Research
- Published
- 2010-02-14
- Volume
- 70
- Issue
- 4
- Pages
- 1555-1563
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2002193311
- Cited by
- 182
- References
- 0
- FWCI
- 17.05
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Irreversible Electroporation Therapy in the Liver: Longitudinal Efficacy Studies in a Rat Model of Hepatocellular Carcinoma. https://app.cochat.ai/papers/10.1158/0008-5472.can-09-3067
- The paper
- Guo, Y., Zhang, Y., Klein, R., Nijm, G. M., Sahakian, A. V., Omary, R. A., Yang, G.-Y., & Larson, A. C. (2010). Irreversible Electroporation Therapy in the Liver: Longitudinal Efficacy Studies in a Rat Model of Hepatocellular Carcinoma. Cancer Research. https://doi.org/10.1158/0008-5472.can-09-3067
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.